XLH patients observed for a decade to uncover disease secrets
NCT ID NCT03745521
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study follows 226 people with X-linked hypophosphatemia (XLH) for up to 10 years. Researchers will collect data on height, walking ability, fractures, and overall health to better understand how the disease progresses and affects daily life. No new treatment is being tested; the goal is to gather information that may improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for X-LINKED HYPOPHOSPHATEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Osaka University Hospital
Osaka, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple scan reveal why muscles tire in phosphate diabetes?
- What It's really like: teens with XLH share their journey as bones stop growing
- Global XLH registry aims to map the disease's journey from childhood to adulthood
- New hope for rare bone disease: first human trial of KK8123 begins
- XLH study: watching the disease, not curing it
- Can a vitamin d pill improve bone health in rare genetic disease?